Effects of the sodium-glucose cotransporter 2 inhibitor dapagliflozin on fluid distribution: A comparison study with furosemide and tolvaptan.
Ohara K, Masuda T, Murakami T, Imai T, Yoshizawa H, Nakagawa S, Okada M, Miki A, Myoga A, Sugase T, Sekiguchi C, Miyazawa Y, Maeshima A, Akimoto T, Saito O, Muto S, Nagata D.
Ohara K, et al. Among authors: masuda t.
Nephrology (Carlton). 2019 Sep;24(9):904-911. doi: 10.1111/nep.13552. Epub 2019 May 2.
Nephrology (Carlton). 2019.
PMID: 30578654